Varia5bility in CKD stage in outpatients followed in two large renal clinics

International Urology and Nephrology

Volumn 44, Issue 5, 2012, Pages 1461-1466

  Sikaneta, Tabo ^a   Abdolell, Mohamed ^a,b   Taskapan, Hulya ^a   Roscoe, Janet ^a   Fung, Jason ^a   Nagai, Gordon ^a   Ting, Robert H ^a   Ng, Paul ^a   Wu, George ^c   Oreopoulos, Dimitrios ^d   Tam, Paul Y ^a  

^a SCARBOROUGH HOSPITAL   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

^c CREDIT VALLEY HOSPITAL   (Canada)

^d TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

CKD outcomes; CKD staging; Estimated GFR

Indexed keywords

ACUTE KIDNEY FAILURE; AGED; ARTICLE; ASIAN; CAUCASIAN; CHRONIC KIDNEY DISEASE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DEATH; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIALYSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; GLOMERULONEPHRITIS; GLOMERULUS FILTRATION RATE; HOSPITAL; HUMAN; HYPERTENSION; HYPERTENSIVE NEPHROSCLEROSIS; INTERSTITIAL RENAL DISEASE; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MULTIPLE MYELOMA RELATED NEPHROPATHY; OUTPATIENT; PROTEINURIA; SOLITARY KIDNEY; CANADA; CHRONIC KIDNEY FAILURE; CLASSIFICATION; OUTPATIENT DEPARTMENT; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK; STATISTICAL MODEL;

ACUTE KIDNEY INJURY; AGED; AMBULATORY CARE FACILITIES; ASIAN CONTINENTAL ANCESTRY GROUP; DIABETIC NEPHROPATHIES; GLOMERULAR FILTRATION RATE; HUMANS; LOGISTIC MODELS; ODDS RATIO; ONTARIO; PROPORTIONAL HAZARDS MODELS; PROTEINURIA; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES;

EID: 84867874246     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-011-9934-9     Document Type: Article

References (12)

1. Coresh J, Selvin E, Stevens LA et al (2007) Prevalence of chronic kidney disease in the United States. JAMA 298:2038-2047
2. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu C (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Eng J Med 351:1296-1305
3. Fried LP, Kronmal RA, Newman AB et al (1998) Risk factors for 5-year mortality in older adults: the cardiovascular health study. JAMA 279:585-592
4. Shlipak MG, Sarnak MJ, Katz R et al (2005) Cystatin C and the risk of death and cardiovascular events among elderly persons. N Eng J Med 352:2049-2060
5. Hostetter TH (2004) Chronic kidney disease predicts cardiovascular disease. N Eng J Med 351:1344-1346
6. Levey AS, Coresh J, Balk E et al (2003) National kidney foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Int Med 139:137-147
7. Levey AS, Bosch JP, Lewis JB et al (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Int Med 130:461-470
8. Foley RN (2010) Temporal trends in the burden of chronic kidney disease in the United States. Curr Opin Nephrol Hyper 19:273-277
9. Amann B, Tinzmann R, Angelkort B (2003) ACE inhibitors improve diabetic nephropathy through suppression of renal MCP-1. Diab Care 26:2421-2425
10. Atkins RC, Briganti EM, Lewis JB et al (2005) Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy. Am J Kidney Dis 45:281-287
11. Palmer AT, Lewis J (2010) Racial differences in chronic kidney disease (CKD) and end-stage renal disease (ESRD) in the United States: a social and economic dilemma. Clin Nephrol 74:s72-s77
12. Levey AS, Greene T, Schluchter MD et al (1993) Glomerular filtration rate measurements in clinical trials. J Am Soc Nephrol 4:1159-1171